Coreceptors--Implications for HIV Pathogenesis and Therapy

  title={Coreceptors--Implications for HIV Pathogenesis and Therapy},
  author={John Percy Moore},
  • J. Moore
  • Published in Science 4 April 1997
  • Biology, Medicine
Last year, the second of the two receptors that HIV uses to enter and infect human cells was identified. In his Perspective, Moore discusses the resulting revolution in thought about how these coreceptor molecules can influence the progress of AIDS and what their existence means for future therapies. 

Chemokines and HIV-1 second receptors: The therapeutic connection

In this review, Scott Cairns and Patricia D'Souza discuss these potentially powerful approaches and how they complement existing antiretroviral drug therapy.

Design and Synthesis of HIV-1 Protease Inhibitors

The C2-symmetric HIV-1 protease is one of the prime targets for chemotherapy in the treatmen with HIV and is the causative agent of Acquired Immune Deficiency Syndrome (AIDS).

Chemokine Receptors and their Crucial Role in Human Immunodeficiency Virus Infection: Major Breakthroughs in HIV Research

This work has shown an increased understanding of viral entry, a connection of viral phenotype to specific coreceptor use, and an unequivocal linkage of a single human gene to host susceptibility for combating HIV.

Co-receptors for HIV-1 entry.

Inhibiting HIV-1 using RNA interference (RNAi) to target novel HIV dependency factors (HDFs)

This paper aims to demonstrate the efforts towards in-situ applicability of EMMARM, which aims to provide real-time information about the response of the immune system to EMTs.

Potential for the transmission of HIV-1 despite highly active antiretroviral therapy.

The use of highly active antiretroviral therapy to control infection with human immunodeficiency virus type 1 (HIV-1) is in many ways a success story. Under optimal circumstances, combinations of d...

gp 41 , A Multifunctional Protein Involved in HIV Entry and Pathogenesis

By analogy with the hemagglutinin of influenza virus, the TM protein is thought to be the engine that drives the membrane fusion process, and it is this multifaceted molecule that is the subject of this review.

C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection☆

The role of chemokines in tissue inflammation and autoimmunity in renal diseases

Recent advances in the field are highlighted, including the discovery of a new class of chemokines, and several novel receptors, and their potential as therapeutic targets are discussed.

Recombinant intracellular antibodies for molecular gene therapy of HIV-1 infection

Tese de doutoramento em Farmacia (Microbiologia), apresentada a Universidade de Lisboa atraves da Faculdade de Farmacia, 2008



Host factors and the pathogenesis of HIV-induced disease

The level of human immunodeficiency virus (HIV) replication in patients reflects a balance between stimulatory and inhibitory host factors (particularly endogenous cytokines). New information

Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals

The results suggest that HIV-1 evolves during the course of infection to use an expanded range of coreceptors for infection, and that this adaptation is associated with progression to AIDS.

Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239

Examination of chemokine receptors for the ability to facilitate the infection of CD4-expressing cells by viruses containing the envelope glycoproteins of a pathogenic simian immunodeficiency virus found CCR5 to be a key entry cofactor.

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5

CD4 binding, although not absolutely necessary for the gp120–CCR-5 interaction, greatly increases its efficiency, and interference with HIV-1 binding to one or both of its receptors (CD4 and CCR-5) may be an important mechanism of virus neutralization.

Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates.

Analysis of isolates obtained sequentially from infected individuals in whom viruses shifted from NSI to SI phenotype during clinical progression exhibited a parallel loss of sensitivity to beta-chemokines, indicating that loss of Sensitivity to Beta-Chemokine inhibition and shift in viral phenotype are not necessarily prerequisites for the pathogenesis of HIV-1 infection.

Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

It is shown that a mutant allele of CCR-5 is present at a high frequency in caucasian populations, but is absent in black populations from Western and Central Africa and Japanese populations, and a 32-base-pair deletion within the coding region results in a frame shift, and generates a non-functional receptor that does not support membrane fusion or infection by macrophage- and dual-tropic HIV-1 strains.

Chemokines and HIV–1 second receptors

Confluence of two fields generates optimism in AIDS research and shows hope for the future in HIV/AIDS research.

Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding

The results suggest that the V1/V2 loops, which have been previously implicated in CD4-modulated, postattachment steps in HIV-1 entry, contribute toCD4-induced gp120 conformational changes detected by the 17b, 48d, and A32 antibodies.

The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression.

The presence of the SI phenotype of HIV is a strong predictor of decline in CD4 cell count and progression of disease; however, controlling for the CD4cell count, theSI phenotype did not increase the immediate risk of death.